| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 743853 | Null | 0.000307626816596602 | 0.51398493 |
| NSC 92915 | ANTINEOPLASTIC-92915 | 0.000307626816596602 | 0.47940448 |
| NSC 652809 | Null | 0.000316293616993019 | 0.2425609 |
| NSC 668814 | 1-Oxa-4,7,10,13,16-pentaazacyclononadecane, cyclic peptide derivative | 0.000316293616993019 | -0.28660739 |
| NSC 677697 | 7H-Pyrrolo[2,3-d]pyrimidine, 5,6-dimethyl- 2,4-bis(methylsulfinyl)-7-phenyl- | 0.000316293616993019 | 0.47029238 |
| NSC 726262 | 1,1'-{[(bispropane-1,N-diyl)piperzine]dioxy}bis[(11aS)-7-met hoxy-1,2,3,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepi n-5-one | 0.000316293616993019 | 0.4022347 |
| NSC 744025 | diethyl 2-[4-(5-[(11aS)-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxypentyl)piperazino]ethylphosphonate | 0.000316293616993019 | 0.39121532 |
| NSC 96996 | B 169 | 0.000316293616993019 | 0.41343413 |
| NSC 625154 | 21-Oxabicyclo[16.2.1]heneicosane-4,9,14,18,20-pentaene, 3,6,8,11,13,16-hexaoxo-2,2,7,7,,12,12,17,17-octamethyl- | 0.000316293616993024 | 0.5437749 |
| NSC 628564 | Null | 0.000316293616993024 | 0.49540202 |